LOGC

LogicBio Therapeutics Inc
2.07
0.00 (0.00%)

LogicBio Therapeutics Inc. (LOGC) Fundamentals

LogicBio Therapeutics Inc is a genome editing company focused on developing medicines to durably treat rare diseases in patients with significant unmet medical need using GeneRide, its proprietary technology platform. Its product candidates include LB-001, LB-101, LB-201 and LB 301.
SHARE INFORMATION
Market Cap$ 68,232,857
Shares Outstanding32,962,733
Float23,418,176
Percent Float71.04%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 5,410,000
Latest Fiscal EPS$ -1.24
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions85
Institutional Holdings Date2022-10-31
Institutional Bought Previous 3 Months530,880
Institutional Holdings Percent38.1%
Institutional Sold Previous 3 Months1,547,643
Insider Holdings Date2022-10-31
Insider Bought Previous 3 Months-
Insider Holdings Percent1.8
Insider Sold Previous 3 Months-
Insider Shares Owned591,389
TRADING INFO
52 Week High$ 2.07
52 Week Low$ 0.26
52 Week High Change$ 38.93
21 Day Moving Average$ 2.07
21 Day Extended Moving Average$ 2.0691
50 Day Moving Average$ 2.0698
50 Day Extended Moving Average$ 1.9995
200 Day Moving Average$ 1.0871
200 Day Extended Moving Average$ 1.6368
10 Day Average Volume-
20 Day Average Volume-
30 Day Average Volume-
50 Day Average Volume7,350
Alpha0.043221
Beta4.5346
Standard Deviation0.965445
R20.070619
7 Day Price Change$ 0.00
7 Day Percent Change0.0%
21 Day Price Change$ 0.00
21 Day Percent Change0.0%
30 Day Price Change$ 0.00
30 Day Percent Change0.0%
Month to Date Price Change$ 0.00
Month to Date Percent Change0.0%
Quarter to Date Price Change$ 0.00
Quarter to Date Percent Change0.0%
180 Day Price Change$ 1.69
180 Day Percent Change437.66%
200 Day Price Change$ 1.67
200 Day Percent Change417.5%
Year to Date Price Change$ 0.00
Year to Date Percent Change0.0%

LogicBio Therapeutics Inc. (LOGC) Key Ratios

PROFITABILITY
EBIT Margin-295.7%
EBITDA Margin-289.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 8,042,000
Revenue Per Share$ 0.244
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book3.30
Total Debt To Equity0.50
Int Coverage-32.30
Current Ratio2.30
Leverage Ratio2.50
Quick Ratio2.10
Long Term Debt To Capital0.24
VALUATION MEASURES
PE Ratio-2.20
Enterprise Value$ 40,473,857
Price to Sales8.4846
Price to Free Cash-3.70
PE High Last 5 Years0.00
Price To Book3.30
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book3.30
MANAGEMENT EFFECTIVENESS
Receivables Turnover70.40
Invoice Turnover0.00
Assets Turnover0.10
Return Assets-53.45
Return on Equity-102.63
Return on Capital-65.39

LogicBio Therapeutics Inc. (LOGC) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorDeloitte & Touche LLP
CEOFrederic Chereau
Emplyoees62
Last AuditUE
CIK0001664106
IndustryBiotechnology
SectorHealthcare
NAICSBiological Product (except Diagnostic) Manufacturing(325414)
CONTACT INFO
Address65 Hayden Avenue
2nd Floor
Lexington, MA 2421
Websitehttps://www.logicbio.com
Facsimile-
Telephone+1 617 245-0399
Emailbluque@logicbio.com


Your Recent History
NASDAQ
LOGC
LogicBio T..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.